Imaging in sarcoidosis

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 1, 2007, Pages 102-120

  Nunes, Hilario ^a   Brillet, Pierre Yves ^a   Valeyre, Dominique ^a   Brauner, Michel W ^a   Wells, Athol U ^b  

^a AVICENNE HOSPITAL   (France)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Chest radiographs; Computed tomographic (CT) scans; Magnetic resonance imaging (MRI); Radionuclide scans; Sarcoidosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ASPERGILLOSIS; BRONCHUS STENOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; LUNG ALVEOLITIS; LUNG FIBROSIS; LUNG FUNCTION TEST; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; SCINTISCANNING; THORAX RADIOGRAPHY;

BRAIN DISEASES; CARDIOMYOPATHIES; DIAGNOSTIC IMAGING; GRANULOMA; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOGRAPHY, THORACIC; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847674390     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970336     Document Type: Review

References (159)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755
2. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005;60:565-582
3. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997;18:755-785
4. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 1963;35:67-89
5. Johns CJ, Michele TM. The clinical management of sarcoidosis: a 50-year experience at the John Hopkins Hospital. Medicine (Baltimore) 1999;78:65-111
6. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. Br Med J 1961;2:1165-1172
7. Mana J, Gomez-Vaquero C, Montero A, et al. Lofgren's syndrome revisited: a study of 186 patients. Am J Med 1999;107:240-245
8. Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med 1973; 78:65-71
9. Bein ME, Putman CE, McLoud TC, Mink JH. A reevaluation of intrathoracic lymphadenopathy in sarcoidosis. AJR Am J Roentgenol 1978;131:409-413
10. Littner MR, Schachter EN, Putman CE, et al. The clinical assessment of roentgenographically atypical pulmonary sarcoidosis. Am J Med 1977;62:361-368
11. Rockoff SD, Rohatgi PK. Unusual manifestations of thoracic sarcoidosis. AJR Am J Roentgenol 1985;144:513-528
12. Conant EF, Glickstein MF, Mahar P, et al. Pulmonary sarcoidosis in the older patient: conventional radiographic features. Radiology 1988;169:315-319
13. Sharma OP, Hewlett R, Gordonson J. Nodular sarcoidosis: an unusual radiographic appearance. Chest 1973;64:189-192
14. Onal E, Lopata M, Lourenco RV. Nodular pulmonary sarcoidosis: clinical, roentgenographic, and physiologic course in five patients. Chest 1977;72:296-300
15. Romer FK. Sarcoidosis with large nodular lesions simulating pulmonary metastases: an analysis of 126 cases of intrathoracic sarcoidosis. Scand J Respir Dis 1977;58:11-16
16. Battesti JP, Saumon G, Valeyre D, et al. Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax 1982;37:448-452
17. Tazi A, Desfemmes-Baleyte T, Soler P, et al. Pulmonary sarcoidosis with a diffuse ground-glass pattern on the chest radiograph. Thorax 1994;49:793-797
18. Rohatgi PK, Schwab LE. Primary acute pulmonary cavitation in sarcoidosis. AJR Am J Roentgenol 1980;134:1199-1203
19. Sharma OP, Gordonson J. Pleural effusion in sarcoidosis: a report of six cases. Thorax 1975;30:95-101
20. Soskel N, Sharma OP. Pleural involvement in sarcoidosis: case presentation and detailed review of the literature. Semin Respir Med 1992;13:492-514
21. Mendelson DS, Norton K, Cohen BA, et al. Bronchial compression: an unusual manifestation of sarcoidosis. J Comput Assist Tomogr 1983;7:892-894
22. Munt PW. Middle lobe atelectasis in sarcoidosis. Am Rev Respir Dis 1973;108:357-360
23. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57:847-852
24. Romer FK. Presentation of sarcoidosis and outcome of pulmonary changes. Dan Med Bull 1982;29:27-32
25. Hillerdal G, Nou E, Osterman K, et al. Sarcoidosis: epidemiology and prognosis: a 15-year European study. Am Rev Respir Dis 1984;130:29-32
26. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996;51:238-247
27. Pietinalho A, Tukiainen P, Haahtela T, et al. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group. Chest 1999;116:424-431
28. Pietinalho A, Tukiainen P, Haahtela T, et al. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest 2002;121:24-31
29. Hansell DM. High-resolution CT of diffuse lung disease: value and limitations. Radiol Clin North Am 2001;39:1091-1113
30. Beigelman-Aubry C, Hill C, Guibal A, Savatovsky J, Grenier PA. Multi-detector row CT and postprocessing techniques in the assessment of diffuse lung disease. Radiographics 2005;25:1639-1652
31. Bergin CJ, Coblentz CL, Chiles C, et al. Chronic lung diseases: specific diagnosis by using CT. AJR Am J Roentgenol 1989;152:1183-1188
32. Mathieson JR, Mayo JR, Staples CA, et al. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989;171:111-116
33. Padley SP, Hansell DM, Flower CD, et al. Comparative accuracy of high-resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol 1991;44:222-226
34. Grenier P, Valeyre D, Cluzel P, et al. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991;179:123-132
35. Grenier P, Chevret S, Beigelman C, et al. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994;191:383-390
36. Nishimura K, Izumi T, Kitaichi M, et al. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases. Chest 1993;104:1149-1155
37. Mana J, Teirstein AS, Mendelson DS, et al. Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax 1995;50:1264-1266
38. Lynch DA, Webb WR, Gamsu G, et al. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 1989;13:405-410
39. Brauner MW, Lenoir S, Grenier P, et al. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 1992;182:349-354
40. Remy-Jardin M, Giraud F, Remy J, et al. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994;191:675-680
41. Murdoch J, Müller NL. Pulmonary sarcoidosis: changes on follow-up CT examination. AJR Am J Roentgenol 1992; 159:473-477
42. Leung AN, Brauner MW, Caillat-Vigneron N, et al. Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. J Comput Assist Tomogr 1998;22:229-234
43. Oberstein A, von Zitzewitz H, Schweden F, Muller-Quernheim J. Noninvasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vase Diffuse Lung Dis 1997;14:65-72
44. Abehsera M, Valeyre D, Grenier P, et al. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000;174:1751-1757
45. Bergin CJ, Bell DY, Coblentz CL, et al. Sarcoidosis: correlation of pulmonary parenchymal pattern at CT with results of pulmonary function tests. Radiology 1989;171:619-624
46. Müller NL, Mawson JB, Mathieson JR, et al. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989;171:613-618
47. Brauner MW, Grenier P, Mompoint D, et al. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 1989;172:467-471
48. Hansell DM, Milne DG, Wilsher ML, et al. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998;209:697-704
49. Davies CW, Tasker AD, Padley SP, et al. Air trapping in sarcoidosis on computed tomography: correlation with lung function. Clin Radiol 2000;55:217-221
50. Magkanas E, Voloudaki A, Bouros D, et al. Pulmonary sarcoidosis: correlation of expiratory high-resolution CT findings with inspiratory patterns and pulmonary function tests. Acta Radiol 2001;42:494-501
51. Drent M, De Vries J, Lenters M, et al. Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 2003;13:2462-2471
52. Terasaki H, Fujimoto K, Muller NL, et al. Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers. AJR Am J Roentgenol 2005;185:333-338
53. Akira M, Kozuka T, Inoue Y, Sakatani M. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest 2005;127:185-191
54. Hamper UM, Fishman EK, Khouri NF, et al. Typical and atypical CT manifestations of pulmonary sarcoidosis. J Comput Assist Tomogr 1986;10:928-936
55. Müller NL, Kullnig P, Miller RR. The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 1989;152:1179-1182
56. Lenique F, Brauner MW, Grenier P, et al. CT assessment of bronchi in sarcoidosis: endoscopic and pathologic correlations. Radiology 1995;194:419-423
57. Sider L, Horton ES Jr. Hilar and mediastinal adenopathy in sarcoidosis as detected by computed tomography. J Thorac Imaging 1990;5:77-80
58. Gawne-Cain ML, Hansell DM. The pattern and distribution of calcified mediastinal lymph nodes in sarcoidosis and tuberculosis: a CT study. Clin Radiol 1996;51:263-267
59. Patil SN, Levin DL. Distribution of thoracic lymphadenopathy in sarcoidosis using computed tomography. J Thorac Imaging 1999;14:114-117
60. Niimi H, Kang EY, Kwong JS, et al. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy. J Comput Assist Tomogr 1996;20:305-308
61. Wells A. High resolution computed tomography in sarcoidosis: a clinical perspective. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:140-146
62. Lynch JP III. Computed tomographic scanning in sarcoidosis. Semin Respir Crit Care Med 2003;24:393-418
63. Nishimura K, Itoh H, Kitaichi M, et al. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology 1993;189:105-109
64. Honda O, Johkoh T, Ichikado K, et al. Comparison of high resolution CT findings of sarcoidosis, lymphoma, and lymphangitic carcinoma: is there any difference of involved interstitium? J Comput Assist Tomogr 1999;23:374-379
65. Nakatsu M, Hatabu H, Morikawa K, et al. Large coalescent parenchymal nodules in pulmonary sarcoidosis: "sarcoid galaxy" sign. AJR Am J Roentgenol 2002;178:1389-1393
66. Remy-Jardin M, Giraud F, Remy J, et al. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189:693-698
67. Gleeson FV, Traill ZC, Hansell DM. Evidence of expiratory CT scans of small-airway obstruction in sarcoidosis. AJR Am J Roentgenol 1996;166:1052-1054
68. Bartz RR, Stern EJ. Airways obstruction in patients with sarcoidosis: expiratory CT scan findings. J Thorac Imaging 2000;15:285-289
69. Fazzi P, Sbragia P, Solfanelli S, et al. Functional significance of the decreased attenuation sign on expiratory CT in pulmonary sarcoidosis: report of four cases. Chest 2001;119:1270-1274
70. Nishino M, Kuroki M, Roberts DH, et al. Bronchomalacia in sarcoidosis: evaluation on volumetric expiratory high-resolution CT of the lung. Acad Radiol 2005;12:596-601
71. Dalal PU, Hansell DM. High-resolution computed tomography of the lungs: the borderlands of normality. Eur Radiol 2006;16:771-780
72. Aye M, Campbell AP, Greenstone MA. An unusual case of lobar collapse. Chest 2002;122:1465-1466
73. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006;61:68-74
74. Narayan D, Brown L, Thayer JO. Surgical management of superior vena caval syndrome in sarcoidosis. Ann Thorac Surg 1998;66:946-948
75. Cappell MS. Endoscopic, radiographic, and manometric findings in dysphagia associated with sarcoid due to extrinsic esophageal compression from subcarinal lymphadenopathy. Am J Gastroenterol 1995;90:489-492
76. Tobias JK, Santiago SM, Williams AJ. Sarcoidosis as a cause of left recurrent laryngeal nerve palsy. Arch Otolaryngol Head Neck Surg 1990;116:971-972
77. Jarman PR, Whyte MK, Sabroe I, Hughes JM. Sarcoidosis presenting with chylothorax. Thorax 1995;50:1324-1325
78. Johkoh T, Ikezoe J, Takeuchi N, et al. CT findings in "pseudoalveolar" sarcoidosis. J Comput Assist Tomogr 1992;16:904-907
79. Liebow AA, The J. Burns Amberson lecture: pulmonary angiitis and granulomatosis. Am Rev Respir Dis 1973; 108:1-18
80. Quaden C, Tillie-Leblond I, Delobbe A, et al. Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiological evaluations. Eur Respir J 2005;26:778-785
81. Mackie B, Humphrey DA, Flannery MT. Atypical sarcoidosis: a case report and literature review. Am J Med Sci 2006;331:277-279
82. Ozseker ZF, Yilmaz A, Bayramgurler B, et al. Cavitary sarcoidosis: analysis of two cases. Respirology 2002;7:289-291
83. Froudarakis ME, Bouros D, Voloudaki A, et al. Pneumothorax as a first manifestation of sarcoidosis. Chest 1997;112:278-280
84. Ichikawa Y, Fujimoto K, Shiraishi T, et al. Primary cavitary sarcoidosis: high-resolution CT findings. AJR Am J Roentgenol 1994;163:745
85. Flora G, Dostanic D, Jakovic R, et al. Pneumothorax in sarcoidosis. Sarcoidosis 1991;8:75-79
86. Padley SP, Padhani AR, Nicholson A, et al. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin Radiol 1996;51:807-810
87. Gruden JF, Webb WR, Naidich DP, McGuinness G. Multinodular disease: anatomic localization at thin-section CT-multireader evaluation of a simple algorithm. Radiology 1999;210:711-720
88. Tsiodras S, Eiger G, Guttentag A, Lippmann M. Sarcoidosis presenting as unilateral alveolar consolidation. Am J Med Sci 1997;314:346-347
89. Gotway MB, Tchao NK, Leung JWT, et al. Sarcoidosis presenting as an enlarging solitary pulmonary nodule. J Thorac Imaging 2001;16:117-122
90. Judson MA, Uflacker R. Treatment of a solitary pulmonary sarcoidosis mass by CT-guided direct intralesional injection of corticosteroid. Chest 2001;120:316-317
91. Ito A, Fujino M, Isada A, et al. Retrograde radiographic development in pulmonary sarcoidosis. Intern Med 2006;45:819-822
92. Marten K, Rummeny EJ, Engelke C. The CT halo: a new sign in active pulmonary sarcoidosis. Br J Radiol 2004;77:1042-1045
93. Marlow TJ, Krapiva PI, Schabel SI, et al. The "fairy ring": a new radiographic finding in sarcoidosis. Chest 1999;115:275-276
94. Weinstein DS. Pulmonary sarcoidosis: calcified micronodular pattern simulating pulmonary alveolar microlithiasis. J Thorac Imaging 1999;14:218-220
95. Szwarcberg JB, Glajchen N, Teirstein AS. Pleural involvement in chronic sarcoidosis detected by thoracic CT scanning. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:58-62
96. Kaiser PK, Lowder CY, Sullivan P, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002;133:499-505
97. Hennebicque AS, Nunes H, Brillet PY, et al. CT findings in severe thoracic sarcoidosis. Eur Radiol 2005;15:23-30
98. Wollschlager C, Khan F. Aspergillomas complicating sarcoidosis: a prospective study in 100 patients. Chest 1984;86:585-588
99. Franquet T, Muller NL, Gimenez A, et al. Spectrum of pulmonary aspergLUosis: histologic, clinical, and radiologic findings. Radiographics 2001;21:825-837
100. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;25:783-788
101. Battesti J-P, Georges R, Basset F, Saumon G. Chronic cor pulmonale in pulmonary sarcoidosis. Thorax 1978;33:76-84
102. Damuth TE, Bower JS, Cho K, Dantzker DR. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 1980;78:888-891
103. Smith LJ, Lawrence JB, Katzenstein AL. Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 1983;285:38-44
104. Hoffstein V, Ranganathan N, Mullen JBM. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 1986;134:809-811
105. Barst RJ, Ratner SJ. Sarcoidosis and reactive pulmonary hypertension. Arch Intern Med 1985;145:2112-2114
106. Craig DA, Colletti PM, Ratto D, et al. MRI findings in pulmonary sarcoidosis. Magn Reson Imaging 1988;6:567-573
107. Mendelson DS, Gray CE, Teirstein AS. Magnetic resonance findings in sarcoidosis of the thorax. Magn Reson Imaging 1992;10:523-529
108. McFadden RG, Carr TJ, Wood TE. Proton magnetic resonance imaging to stage activity of interstitial lung disease. Chest 1987;92:31-39
109. Muller NL, Mayo JR, Zwirewich CV. Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT. AJR Am J Roentgenol 1992;158:1205-1209
110. Primack SL, Mayo JR, Hartman TE, et al. MRI of infiltrative lung disease: comparison with pathologic findings. J Comput Assist Tomogr 1994;18:233-238
111. Gaeta M, Blandino A, Scribano E, et al. Chronic infiltrative lung diseases: value of gadolinium-enhanced MRI in the evaluation of disease activity-early report. Chest 2000;117:1173-1178
112. Mana J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med 2002;8:457-463
113. Jacobs MP, Baughman RP, Hughes J, Fernandez-Ulloa M. Radioaerosol lung clearance in patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1985;131:687-689
114. Dusser DJ, Collignon MA, Stanislas-Leguern G, et al. Respiratory clearance of 99mTc-DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis 1986;134:493-497
115. Thunberg S, Larsson K, Eklund A, Blaschke E. 99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis: studies of reproducibility and relation to bronchoalveolar lavage findings. Eur J Nucl Med 1989;15:71-77
116. Chinet T, Dusser D, Labrune S, et al. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. Am Rev Respir Dis 1990;141:445-449
117. Bradvik I, Wollmer P, Evander E, et al. Different kinetics of lung clearance of technetium-99m labelled diethylene triamine penta-acetic acid in patients with sarcoidosis and smokers. Eur J Nucl Med 1994;21:1218-1222
118. Bradvik I, Wollmer P, Evander E, et al. One year follow-up of lung clearance of 99mTc-diethylene triamine penta-acetic acid and disease activity in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:281-287
119. Bradvik I, Wollmer P, Evander E, et al. Kinetics of lung clearance of 99mTc-DTPA in smoking patients with sarcoidosis compared to healthy smokers. Respir Med 2002; 96:317-321
120. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004;3:397-407
121. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 2004; 182:289-295
122. Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol 1999;20:655-669
123. Hayes WS, Sherman JL, Stern BJ, et al. MR and CT evaluation of intracranial sarcoidosis. AJR Am J Roentgenol 1987;149:1043-1049
124. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJR Am J Roentgenol 1990;155:1293-1301
125. Seltzer S, Mark AS, Atlas SW. CNS sarcoidosis: evaluation with contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991;12:1227-1233
126. Dumas JL, Valeyre D, Chapelon-Abric C, et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology 2000;214:411-420
127. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol 1994;15:973-982
128. Junger SS, Stern BJ, Levine SR, et al. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 1993;43:333-337
129. Pickuth D, Heywang-Kobrunner SH. Neurosarcoidosis: evaluation with MRI. J Neuroradiol 2000;27:185-188
130. Koike H, Misu K, Yasui K, et al. Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis. J Neurol 2000;247:544-549
131. Doughan AR, Williams BR. Cardiac sarcoidosis. Heart 2006;92:282-288
132. Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest 2004;126:1372-1376
133. Barneveld PC, van Leeuwen C, van Isselt JW. Scintigraphic demonstration of myocardial sarcoidosis: the added value of single-photon emission computed tomography. J Nucl Cardiol 1997;4:256-257
134. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184:249-254
135. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med 2001;110:520-527
136. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002;26:762-767
137. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002; 122:1895-1901
138. Skold CM, Larsen FF, Rasmussen E, et al. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and Doppler echocardiography. J Intern Med 2002;252:465-471
139. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-1690
140. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005;185:110-115
141. Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629-1637
142. Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med 2003;44:1030-1036
143. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-1998
144. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-1543
145. Kaminaga T, Takeshita T, Yamauchi T, et al. The role of iodine-123-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid scintigraphy in the detection of local myocardial involvement of sarcoidosis. Int J Cardiol 2004;94:99-103
146. Hyodo E, Hozumi T, Takemoto Y, et al. Early detection of cardiac involvement in patients with sarcoidosis by a non-invasive method with ultrasonic tissue characterisation. Heart 2004;90:1275-1280
147. Kanao S, Tadamura E, Yamamuro M, et al. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging. J Comput Assist Tomogr 2005;29:745-748
148. Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990;31:1909-1914
149. Israel HL, Albertine KH, Park CH, Patrick H. Whole-body gallium 67 scans: role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991;144:1182-1186
150. Sulavik SB, Spencer PP, Palestro CJ, et al. Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest 1993;103:403-409
151. Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990;31:1909-1914
152. Line BR, Hunninghake GW, Keogh BA, et al. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function tests and bronchoalveolar lavage. Am Rev Respir Dis 1981;123:440-446
153. Fajman WA, Greenwald LV, Staton G, et al. Assessing the activity of sarcoidosis: quantitative 67Ga-citrate imaging. AJR Am J Roentgenol 1984;142:683-688
154. Alberts C, van der Schoot JB, van Daatselaar JJ, et al. 67Ga scintigraphy, serum lysozyme and angiotensin-converting enzyme in pulmonary sarcoidosis. Eur J Respir Dis 1983;64:38-46
155. Beaumont D, Herry JY, Sapene M, et al. Gallium-67 in the evaluation of sarcoidosis: correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage. Thorax 1982;37:11-18
156. Kohn H, Klech H, Kummer F, Mostbeck A. Assessment of activity in Sarcoidosis: sensitivity and specificity of 67-Gallium scintigraphy, serum ACE levels, chest roentgenography and blood lymphocyte subpopulations. Chest 1982; 82:732-738.
157. Duffy GJ, Thirumurthi K, Casey M, et al. Semi-quantitative gallium-67 lung scanning as a measure of the intensity of alveolitis in pulmonary sarcoidosis. Eur J Nucl Med 1986;12:187-191
158. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21:297-305
159. Yamada Y, Uchida Y, Tatsumi K, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 1998;39:1160-1166